129 related articles for article (PubMed ID: 19001328)
21. The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
Wasmuth HE; Zaldivar MM; Berres ML; Werth A; Scholten D; Hillebrandt S; Tacke F; Schmitz P; Dahl E; Wiederholt T; Hellerbrand C; Berg T; Weiskirchen R; Trautwein C; Lammert F
J Hepatol; 2008 Feb; 48(2):208-15. PubMed ID: 18078680
[TBL] [Abstract][Full Text] [Related]
22. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
[TBL] [Abstract][Full Text] [Related]
23. The CX3CL1-CX3CR1 system and psoriasis.
Plant D; Young HS; Watson RE; Worthington J; Griffiths CE
Exp Dermatol; 2006 Nov; 15(11):900-3. PubMed ID: 17002687
[TBL] [Abstract][Full Text] [Related]
24. Glioblastoma multiforme with long term survival.
Deb P; Sharma MC; Mahapatra AK; Agarwal D; Sarkar C
Neurol India; 2005 Sep; 53(3):329-32. PubMed ID: 16230803
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma.
Carpentier C; Laigle-Donadey F; Marie Y; Auger N; Benouaich-Amiel A; Lejeune J; Kaloshi G; Delattre JY; Thillet J; Sanson M
Neurology; 2006 Sep; 67(5):872-4. PubMed ID: 16885506
[TBL] [Abstract][Full Text] [Related]
26. Analysis of CCR5 and CX3CR1 gene polymorphisms in association with unexplained recurrent miscarriages among north Indian women.
Parveen F; Faridi RM; Singh B; Agrawal S
Cytokine; 2011 Nov; 56(2):239-44. PubMed ID: 21820915
[TBL] [Abstract][Full Text] [Related]
27. Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme.
McGirt MJ; Mukherjee D; Chaichana KL; Than KD; Weingart JD; Quinones-Hinojosa A
Neurosurgery; 2009 Sep; 65(3):463-9; discussion 469-70. PubMed ID: 19687690
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
[TBL] [Abstract][Full Text] [Related]
29. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma.
El Hallani S; Ducray F; Idbaih A; Marie Y; Boisselier B; Colin C; Laigle-Donadey F; Rodéro M; Chinot O; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
Neurology; 2009 Jan; 72(4):332-6. PubMed ID: 19171829
[TBL] [Abstract][Full Text] [Related]
30. Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis.
Prayson NF; Angelov L; Prayson RA
Ann Diagn Pathol; 2009 Oct; 13(5):291-6. PubMed ID: 19751904
[TBL] [Abstract][Full Text] [Related]
31. Lack of association between CX3CR1 V249I and T280M polymorphisms and risk of Parkinson's disease in a Greek population.
Kalinderi K; Bostantjopoulou S; Katsarou Z; Clarimón J; Fidani L
Genet Test Mol Biomarkers; 2012 Aug; 16(8):974-7. PubMed ID: 22747084
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
33. Increased frequency of CD4+T cells expressing fractalkine receptor CX3CR1 in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), but its AIDS susceptible polymorphisms are not associated with the disease.
Saito M; Usuku K; Arimura K; Izumo S; Osame M; Ohara Y
J Neurol Sci; 2008 Mar; 266(1-2):13-9. PubMed ID: 17884099
[TBL] [Abstract][Full Text] [Related]
34. Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.
Singh N; Rai H; Sinha N; Kumar S; Pandey CM; Agrawal S
Genet Test Mol Biomarkers; 2012 Jul; 16(7):756-60. PubMed ID: 22731642
[TBL] [Abstract][Full Text] [Related]
35. The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.
Marchesi F; Piemonti L; Fedele G; Destro A; Roncalli M; Albarello L; Doglioni C; Anselmo A; Doni A; Bianchi P; Laghi L; Malesci A; Cervo L; Malosio M; Reni M; Zerbi A; Di Carlo V; Mantovani A; Allavena P
Cancer Res; 2008 Nov; 68(21):9060-9. PubMed ID: 18974152
[TBL] [Abstract][Full Text] [Related]
36. The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.
Stojković L; Djurić T; Stanković A; Dinčić E; Stančić O; Veljković N; Alavantić D; Zivković M
J Neuroimmunol; 2012 Apr; 245(1-2):87-92. PubMed ID: 22261545
[TBL] [Abstract][Full Text] [Related]
37. CX3CR1 polymorphisms are associated with atopy but not asthma in German children.
Depner M; Kormann MS; Klopp N; Illig T; Vogelberg C; Weiland SK; von Mutius E; Combadière C; Kabesch M
Int Arch Allergy Immunol; 2007; 144(1):91-4. PubMed ID: 17505143
[TBL] [Abstract][Full Text] [Related]
38. Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
Niessner A; Marculescu R; Kvakan H; Haschemi A; Endler G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 Dec; 94(6):1251-6. PubMed ID: 16411402
[TBL] [Abstract][Full Text] [Related]
39. Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantation.
Courivaud C; Bamoulid J; Loupy A; Deschamps M; Ferrand C; Simula-Faivre D; Tiberghien P; Chalopin JM; Legendre C; Thervet E; Borg C; Saas P; Ducloux D
Transplantation; 2013 Mar; 95(5):728-32. PubMed ID: 23388733
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
